![Pierre Kyme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Kyme
Public Communications Contact at
ARMATA PHARMACEUTICALS, INC.
Net worth: 36 446 $ as of 31/05/2026
Profile
Pierre Kyme currently works at Special Phage Services Pty Ltd., as Director, Special Phage Holdings Pty Ltd., as Director, AmpliPhi Australia Pty Ltd., as Director, C3J Therapeutics, Inc., as Director-Product Development from 2012, and Armata Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Dr. Kyme received his doctorate degree from The University of Sydney.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/04/2026 | 4,461 ( 0.01% ) | 36 446 $ | 31/05/2026 |
Pierre Kyme active positions
| Companies | Position | Start |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Public Communications Contact | - |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Corporate Officer/Principal | 01/01/2012 |
AmpliPhi Australia Pty Ltd.
 AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Director/Board Member | - |
Special Phage Holdings Pty Ltd.
 Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Director/Board Member | - |
Special Phage Services Pty Ltd.
 Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Director/Board Member | - |
Training of Pierre Kyme
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Special Phage Services Pty Ltd.
Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Health Technology |
Special Phage Holdings Pty Ltd.
Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Health Technology |
AmpliPhi Australia Pty Ltd.
AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
- Stock Market
- Insiders
- Pierre Kyme
